BOCCARELLI, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 3.486
EU - Europa 832
AS - Asia 483
OC - Oceania 4
SA - Sud America 1
Totale 4.806
Nazione #
US - Stati Uniti d'America 3.481
CN - Cina 427
SE - Svezia 282
IT - Italia 159
UA - Ucraina 109
DE - Germania 97
FI - Finlandia 86
GB - Regno Unito 37
SG - Singapore 23
IN - India 19
BE - Belgio 15
FR - Francia 14
IE - Irlanda 13
RU - Federazione Russa 10
CA - Canada 5
CZ - Repubblica Ceca 5
IR - Iran 5
AU - Australia 4
VN - Vietnam 4
KR - Corea 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
Totale 4.806
Città #
Fairfield 400
Woodbridge 374
Chandler 370
Jacksonville 262
Ashburn 242
Nyköping 242
Houston 209
Seattle 190
Cambridge 171
Ann Arbor 164
Wilmington 156
Bari 101
Nanjing 101
Lawrence 88
Roxbury 88
Beijing 79
New York 78
Des Moines 60
Boardman 53
Princeton 38
Inglewood 31
Helsinki 30
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 24
San Diego 22
Brooklyn 18
Jiaxing 18
Pune 16
Brussels 15
Tianjin 15
Dublin 12
Los Angeles 12
Guangzhou 10
Milan 9
Singapore 9
Changsha 7
Kunming 7
Ningbo 7
Paris 7
Shanghai 7
San Francisco 6
Washington 6
Wuxi 6
Ardabil 5
Brno 5
Hefei 5
Dong Ket 4
Jinan 4
Leawood 4
Redwood City 4
Taizhou 4
Toronto 4
Wuhan 4
Auburn Hills 3
Lanzhou 3
London 3
Marseille 3
San Mateo 3
Terlizzi 3
Yiwu 3
Zhengzhou 3
Augusta 2
Baotou 2
Berlin 2
Dongyang 2
Edinburgh 2
Grafing 2
Jinhua 2
Kilburn 2
Melbourne 2
Monmouth Junction 2
Mumbai 2
Munich 2
Nantong 2
Bandar Seri Begawan 1
Brescia 1
Brisbane 1
Chicago 1
Chiswick 1
Dalian 1
Falls Church 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Harbin 1
Heze 1
Hounslow 1
Indiana 1
La Canada Flintridge 1
Ljubljana 1
Markham 1
Modugno 1
New Orleans 1
Norwalk 1
Qingdao 1
Quanzhou 1
Riyadh 1
Rome 1
Totale 3.953
Nome #
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 137
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 130
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 126
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 125
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 118
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 113
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 106
null 104
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 101
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 98
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 90
null 90
null 88
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 84
Platinum(II) based anticancer agents with a trans geometry 79
Endothelial cells in the bone marrow of patients with multiple myeloma 78
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 77
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 74
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 71
Antitumour platinum iminoether complexes 68
Antitumour platinum-iminoether complexes 68
null 68
null 67
null 66
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 66
null 65
null 65
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 63
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 61
Antitumour platinum iminoether complexes 60
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 59
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 59
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 59
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 57
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 57
Antitumour ruthenium(II)-dimethylsulfoxide complexes 57
null 55
null 55
Antitumor activity of trans platinum complexes 54
Inhibition of matrix metallo proteinases activity by platinum complexes 53
null 53
null 52
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 51
Bone Marrow Fibroblasts and Multiple Myeloma Progression 51
null 51
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 50
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 49
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 49
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 49
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 47
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 46
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 45
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 44
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 44
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 44
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 43
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 43
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 42
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 41
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 39
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 38
Complessi antitumorali di platino a geometria trans 38
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 37
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 36
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 36
null 33
null 33
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 32
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 32
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 30
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 30
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 29
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 29
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 29
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 28
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 28
null 28
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 28
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 26
A new generation of platinum anticancer complexes with trans geometry 26
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 24
Interazione DNA-isomeri del [PtCl2(DACH)] 24
Screening tests for selecting anticancer metal compounds 22
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 22
DNA interaction properties of platinum –iminoether complexes 21
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 21
New platinum antitumor complexes with chiral diamines 20
Platinum(II) complexes with acyclovir: synthesis and biological activity 19
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 18
Complessi antitumorali di platino a geometria trans 18
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 18
A trans-platinum complex showing higher antitumor activity than the cis congeners 17
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 17
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 16
Complessi antimetastatici di rutenio 15
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 15
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 15
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 13
Synthesis and antitumour activity of two new trans-[PtCl2(iminoether)2] complexes 13
Synthesis, Biophysical Studies, and Antiproliferative Activity of Platinum(II) Complexes Having 1,2-Bis(aminomethyl)carbobicyclic Ligands 13
Totale 5.091
Categoria #
all - tutte 20.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020884 0 57 27 90 96 63 112 74 105 70 174 16
2020/2021957 111 80 108 36 123 67 47 51 118 109 74 33
2021/2022555 15 90 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024432 30 50 19 18 60 135 4 33 11 10 3 59
2024/2025112 89 23 0 0 0 0 0 0 0 0 0 0
Totale 5.160